Read More 1 minute read Analyst Ratings News Price Target Reiteration Credit Suisse Reiterates Underperform on CF Industries Holdings, Maintains $75 Price Target By Benzinga Newsdesk February 16, 9:38 AM Credit Suisse analyst Edlain Rodriguez reiterates CF Industries Holdings (NYSE:CF) with a Underperform and maintains $75 price target. CF
Read More 1 minute read Analyst Ratings News Price Target Reiteration Credit Suisse Reiterates Underperform on Tronox Holdings, Maintains $10 Price Target By Benzinga Newsdesk February 16, 9:36 AM Credit Suisse analyst John Roberts reiterates Tronox Holdings (NYSE:TROX) with a Underperform and maintains $10 price target. TROX
Read More 1 minute read Analyst Ratings News Price Target Reiteration Credit Suisse Reiterates Neutral on SunPower, Maintains $15 Price Target By Benzinga Newsdesk February 16, 9:28 AM Credit Suisse analyst Maheep Mandloi reiterates SunPower (NASDAQ:SPWR) with a Neutral and maintains $15 price target. SPWR
Read More 1 minute read Analyst Ratings News Price Target Reiteration Rosenblatt Reiterates Buy on CEVA, Maintains $45 Price Target By Benzinga Newsdesk February 16, 9:00 AM Rosenblatt analyst Kevin Cassidy reiterates CEVA (NASDAQ:CEVA) with a Buy and maintains $45 price target. CEVA
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on Karyopharm Therapeutics, Maintains $16 Price Target By Benzinga Newsdesk February 16, 8:45 AM HC Wainwright & Co. analyst Edward White reiterates Karyopharm Therapeutics (NASDAQ:KPTI) with a Buy and maintains $16 price target. KPTI
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on Seagen, Maintains $160 Price Target By Benzinga Newsdesk February 16, 7:27 AM Needham analyst Ami Fadia reiterates Seagen (NASDAQ:SGEN) with a Buy and maintains $160 price target. SGEN
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on Biogen, Maintains $325 Price Target By Benzinga Newsdesk February 16, 7:13 AM HC Wainwright & Co. analyst Andrew Fein reiterates Biogen (NASDAQ:BIIB) with a Buy and maintains $325 price target. BIIB
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on Seagen, Maintains $180 Price Target By Benzinga Newsdesk February 16, 7:11 AM HC Wainwright & Co. analyst Andrew Fein reiterates Seagen (NASDAQ:SGEN) with a Buy and maintains $180 price target. SGEN
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on ProPhase Labs, Maintains $15 Price Target By Benzinga Newsdesk February 16, 7:09 AM HC Wainwright & Co. analyst Yi Chen reiterates ProPhase Labs (NASDAQ:PRPH) with a Buy and maintains $15 price target. PRPH
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on Upwork, Lowers Price Target to $18 By Benzinga Newsdesk February 16, 7:01 AM Needham analyst Bernie McTernan reiterates Upwork (NASDAQ:UPWK) with a Buy and lowers the price target from $19 to $18. UPWK